The Increasing Adoption Of Research Antibodies In Drug Discovery To Open Up New Avenue For The Research Antibodies Market
Research Antibodies Market |
The Research Antibodies Market is estimated to be valued at US$ 3785.5 Bn or Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Research antibodies are broadly used across various applications including
proteomics, drug discovery, genomics and others. They help in identifying
specific proteins and antibodies that play important roles in the physiological
and pathological cellular processes. They are extensively used in research to
detect, measure and purify proteins along with other cellular components. The
common types of research antibodies include primary antibodies, secondary
antibodies and isotype controls.
Market Dynamics:
Research antibodies market growth is driven by growing investments in
biomedical research and rising focus on disease diagnosis and drug discovery.
According to Pharmaceutical Research and Manufacturers of America (PhRMA), the
U.S. biopharmaceutical companies invested over US$ 83 billion in the research
and development of new medicines and vaccines in 2020. Growing funding in healthcare
research has prompted pharmaceutical companies and research institutes to adopt
more advanced technologies, thereby positively impacting the market growth.
Moreover, rising prevalence of chronic diseases worldwide has accelerated the
search for novel therapeutic targets and drug development processes, which
involves use of antibodies for screening purposes. According to World Health
Organization (WHO), chronic diseases accounted for approximately 60% of all
deaths globally in 2020. This has increased the demand for research tools like
antibodies in drug discovery and development activities.
Market Dynamics:
Growing investments in biomedical research and rising focus on disease
diagnosis and drug discovery are the major market drivers. According to
Pharmaceutical Research
Segment Analysis
The research antibodies market is dominated by the primary antibodies segment,
which holds over 60% share of the total market. Primary antibodies are directly
labeled or unlabeled and play a crucial role in various research applications
such as western blotting, immunofluorescence, immunohistochemistry,
immunoprecipitation etc. owing to their high specificity and affinity towards
target antigens. The major factor attributed to the large share of this segment
is the wide application of primary antibodies in various research procedures.
PEST Analysis
Political: Government fundings and grants for research activities have
influenced the growth of this market. Various initiatives focusing on advancing
healthcare and drug development support the demand.
Economic: Rising research expenditure from pharmaceutical and biotechnology
companies along with increased funding for healthcare has propelled the market
growth.
Social: Growing awareness about disease diagnosis and increasing incidence of
chronic diseases have fueled research activities, augmenting demand.
Technological: Developments in epitope tagging, humanization of antibodies and
antibody engineering have widened the scope of applications and driven the
market.
Key Takeaways
Global
Research Antibodies Market Size is expected to witness high growth,
exhibiting CAGR of 5.9% over the
forecast period, due to increasing research activities in drug discovery and
precision medicine.
The North America region dominates the research antibodies market and is
expected to retain its dominance over the forecast period. This can be
attributed to presence of large number of pharmaceutical & biotechnology
companies and CROs in the region along with rising healthcare expenditure.
Key players operating in the research antibodies market are Thermo Fisher
Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signalling
Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical
Company, Agilent Technologies, Danaher Corporation, BioLegend Inc., Illumina,
Phoenix Pharmaceuticals, Abcam plc. These players are focusing on new product
launches, expansions and collaborations to gain significant market share.
Comments
Post a Comment